The effect of brief myocardial ischemia on the expression of heat shock protein (HSP 70) 
Introduction
Repetitive brief ischemia has been shown to have prolonged effects on hemodynamic function and high-energy phosphate levels (1) (2) (3) (4) (5) (6) (7) . This combination of reduced high-energy phosphates and depressed hemodynamic function has been termed "stunning" (8) . A protective effect of brief ischemia preceding prolonged ischemia has also been described, and this has been termed "preconditioning" (4) . Although the effects ofstunning and preconditioning have been well described, the mechanisms remain elusive. We postulated that even a briefepisode ofischemia, the experimental equivalent ofan anginal episode, might have an effect on gene expression, and that altered gene expression could have a role in myocardial stunning and precondiThis study was presented in part at the American Heart Association Scientific Sessions, New Orleans, LA, November 1989.
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tioning. A likely change would be an increase in the expression of the major heat shock protein, HSP 70,' as heat shock proteins are expressed in response to numerous stresses in other tissues and organisms (9, 10) . HSP 70 has been observed to increase in the heart in response to prolonged ischemia ofsufficient duration to result in infarction (1 1) and in response to pressure overload (12, 13) . The induction of HSP 70 in pressure overload occurs simultaneously with the induction of the proto-oncogenes, c-myc and c-fos (13) and precedes the induction of the genes for the fetal isoforms of the contractile proteins. Cell cycle-dependent changes in HSP 70 expression in cell culture (HeLa cells) have raised the possibility that this protein has a role in regulation ofcell growth (14) . In addition, HSP 70 has been shown to be preferentially translated to the exclusion of other mRNAs, raising the possibility that its expression might have a direct role in stunning by effectively inhibiting the translation of other proteins (9, 10, 15) . Although the majority of studies of myocardial stunning have focused on the canine model, there have been studies in other species, such as the pig (16) and ferret (17) . A previous study from our laboratory examined repetitive ischemia in the isolated blood-perfused rabbit heart. In those studies, stunning, characterized by depressed systolic and diastolic function, was observed after four cycles of 5 min of ischemia/5 min of reperfusion (18) . To examine this phenomena in a more physiologic in vivo model, New Zealand white rabbits were subjected to brief cardiac ischemia and reperfusion. Function was assessed using piezoelectric crystals implanted in the myocardial wall and HSP 70 expression was determined by measuring steadystate mRNA levels and by Western blot analysis.
Methods
Male New Zealand white rabbits, 1.5-2.5 kg in size, were used for all studies. For studies of normal tissue, the rabbits were overdosed with intravenous pentobarbital, 75 mg/kg, and the hearts were immediately removed, dissected, and frozen in liquid nitrogen. Time from removal to freezing was < 30 s. For studies of ischemia, rabbits were anesthetized with intravenous pentobarbital, intubated, and then mechanically ventilated as previously described (19) . Xylocaine was used as an additional local anesthetic during the initial surgical procedure. All rabbits received 3 ml of a 1% solution subcutaneously. Thoracotomy was performed and a silk snare was placed around the large marginal branch of the circumflex artery midway between the atrioventricular groove and the apex. Ischemia was induced by tightening the snare for 5 min with a clamp and releasing it. Ischemia and reperfusion were verified in these experiments by visual inspection. All rabbits had a carotid artery catheter placed for monitoring systemic pressure. 42 rabbits underwent these protocols. They were divided into two groups. One group (12 rabbits) underwent more detailed measurement offunction as described below. 30 rabbits were used for biochemical measure-ments. There was one operative death. Two rabbits were excluded because they developed brief ventricular fibrillation during one of the reperfusion cycles.
To assess the effect ofrepetitive ischemia in the in vivo rabbit heart, a pair of 5-MHz piezoelectric crystals were placed in the ischemic zone perpendicular to the main axis ofthe heart. The crystals, which were of I mm diam, were placed in the midwall of the left ventricle 5-12 mm apart (Fig. 1 ). For most of the studies only a single pair of crystals was used because of the small size of the rabbit heart. In two rabbits a second pair of crystals was placed in the nonischemic region ofthe left ventricle perpendicular to the main axis of the heart. Signal from the crystals was monitored using a dual-beam oscilloscope (Tektronics, Inc., Beaverton, OR), and output from a sonomicrometer (model 120, Triton Technology, San Diego, CA), was recorded by mean of a fourchannel recorder (Gould, Inc., Cleveland, OH). An intramyocardial electrocardiogram was obtained from the crystals and recorded on a separate channel. The systemic pressure, systolic, diastolic, and mean were recorded on a third channel. The recorder was run at 0.05-50 mm/s throughout the experiment. Using this method systemic pressure, heart rate, end-diastolic length, end-systolic length, and segmental shortening were determined. Measurements were made at baseline, and at I min and 4 min 45 s ofeach ischemia and reperfusion cycle. All hearts on visual inspection were clearly ischemic in the region of the crystals after occlusion as evidenced by visual cyanosis and visual hypokinesis to dyskinesis. The segment length changes during ischemia demonstrated severe hypokinesis to dyskinesis. In addition, ST segment elevation was evident on electrocardiogram. After the four cycles ofischemia and reperfusion, the chest was closed and monitoring ofall parameters continued for another 3 h. During the first hour ofrecovery measurements were made every 10 min. Thereafter measurements crystals Figure 1 . Illustration of the study preparation. An were made every 15 min. At 3 h, the rabbits were overdosed with pentobarbital, the hearts were removed, and the position of the crystals was verified. Hearts were then sliced breadloaf fashion and stained with nitroblue tetrazolium as previously described to exclude any necrosis (19) (20) (21) . In two rabbits placement of the crystals was technically difficult and complicated in one by a small branch arterial bleed and in another by clear occlusion of a branch vessel when the crystal was sutured in place. Both of these hearts had small infarcts distal to the crystals by nitroblue tetrazolium stain, and were therefore excluded from analysis. In two rabbits in the last hour of monitoring, the signal from the crystals could not be fully analyzed secondary to artifact.
End-diastolic and end-systolic lengths were determined from the strip chart recording. End diastole was timed from the onset ofthe QRS and end systole from the dicrotic notch. Segmental shortening was calculated by the following equation (EDL = end-diastolic length, ESL = end-systolic length, and SS = segmental shortening): 100 x (EDL-ESL)/EDL = %SS.
The velocity of shortening (dL/dt) was derived from the segment length recordings on three to five consecutive beats, and was expressed as a percentage of the baseline value because of the variability among individuals.
For the biochemical studies both four cycles of 5 min ofischemia/5 min of reperfusion and a single 5-min occlusion with reperfusion were examined. At the completion of the protocol the snare was left loosely in place to mark its position, and the chest was closed. 2 h later the rabbits were overdosed with pentobarbital and the hearts were removed as described above. Tissue samples from the ischemic zone, immediately below the snare, and the nonischemic zone, the upper left ventricular free wall, and septum were frozen rapidly in liquid nitrogen. Additional groups subjected to repetitive ischemia were overdosed at 1, 4, and 24 h to determine the time course of acute changes in mRNA levels. In two rabbits the heart was removed after coronary occlusion for 2 h 35 min. This matched the total time course for the 5 min x 4 protocol followed by 2 h of reperfusion (i.e., the 2-h group).
Four sham-operated controls underwent the same surgical protocol as the experimental group, including incising the pericardium, except no coronary occlusion was done. Two ofthe four had a snare placed in the myocardium. The chests were left open for 35 min, the same duration as with the repetitive ischemia protocol, and the rabbits were overdosed 2 h after completion of the sham protocol. This was done to determine whether a change in mRNA levels was induced by anesthesia or surgical manipulation of the heart. Direct comparison of the sham-operated hearts with normal ventricles showed there was no change in expression of HSP 70 mRNA.
RNA isolation and analysis. These procedures were performed using the guanidinium thiocyanate/cesium chloride centrifugation method of Chirgwin et al. (22) with slight modification. For Northern blot analysis, total cellular RNA was separated electrophoretically as previously described (23) . Northern blotting was performed by vacuum transfer (Stratavac, Stratagene, New Haven, CT) in 1.5 M NaCl/l .5 M sodium citrate, pH 7 (l0x SSC), to a nylon membrane (Genescreen, Dupont/New England Nuclear, Boston, MA). After transfer, the membrane was washed in 0.3 M NaCl/0.3 M sodium citrate, pH 7, (2X SSC) and UV cross-linking was performed using a Stratalinker apparatus (Stratagene). Prehybridization was carried out as recommended by the manufacturer of the nylon membrane. Hybridization was then performed overnight using cDNA probes labeled by random hexamer priming with [32P]dCTP using a commercial kit (Amersham Corp., Arlington Heights, IL). After hybridization, membranes were washed with 1% SDS and 0.15 M NaCI/0. 15 M sodium citrate, pH 7 (I x SSC), for 10 min at 52 to 55°C and then for 2 min at 52-55°C. Blots were exposed to preflashed X-Omat film (Eastman Kodak Co., Rochester, NY) at -70 C. Laser densitometry was performed when appropriate.
Dot blot analysis. This procedure was performed using a dot blotting apparatus (BioRad Laboratories, Richmond, CA). 2, 5, and 10 sg of RNA was applied to nylon membranes (Genescreen). Membranes were washed in 2x SSC and then cross-linked as described above. Hybridization was carried out as described above for Northern blot analy-sis, using 25-50 ng ofthe cDNA for individual hybridizations. Dot blot antibody was originally developed (29) significant. All numbers are reported as mean±SEM unless stated oth-MD) and has been described previously (24, 25) . The EcoRI/Hind III erwise.
1. I-kb fragment of PE123 for collagen al(IV) (26) and the Hind III/ XbaI 500-bp fragment ofpUCI 3 for G3PD (27) were used as controls.
Results
Gel electrophoresis and western blotting. A cytosolic extract ofcardiac tissue was prepared as previously described (28 line (Fig. 4) . End-systolic length increased with each period of ischemia, and decreased with reperfusion (Fig. 4, top) . Enddiastolic length increased with each reperfusion and by the final reperfusion was 106.4% of baseline (P < 0.05, Fig. 4 , bottom). With each successive ischemic episode the end-systolic length increased and reached 120.5% of baseline by the end of the fourth period of ischemia (P < 0.05 vs. baseline). During recovery, 3 h after the fourth period ofischemia, both end-diastolic and end-systolic length were persistently elevated, and were 106±2 and 105.5±2% ofbaseline, respectively, after 3 h of reperfusion. In contrast to the changes in segment length observed in the ischemic region, the measurements made in the nonischemic regions (n = 2) showed an increase in end-diastolic length of 2-7% ofbaseline with ischemia whereas the end-systolic length remained unchanged and segmental shortening increased. During the 3-h recovery period end-diastolic length decreased to 92-99% of baseline. End-systolic length varied similarly.
The velocity of shortening, dL/dt, was reduced after repetitive ischemia in the ischemic region. At 5 min after the final reperfusion dL/dt was 73.2±7.2% ofbaseline (P < 0.05). dL/dt increased to 79.4±8.4% ofbaseline at 1 h, and 83.5±10.3% at 3 h of reperfusion (P < 0.05 for both values).
As shown in Table I , mean heart rate varied between 226±10.0 and 237±7 beats/min during the protocol. The mean aortic pressure ranged from 65±5.2 to 82.1±4.4 mm Hg. Mean pressure decreased 8-12 mm Hg with each ischemic episode (P < 0.05), and returned to baseline with reperfusion. There was no significant change in heart rate during the pro- (Fig. 5 A) . Repetitive ischemia with four 5-min occlusions resulted in a 2.3-fold increase compared with nonischemic tissue from the same ventricle (n = 5, P = 0.006) shown in Fig. 5 B.
The time course for the increase in HSP 70 mRNA in the ischemic region after repetitive ischemia is shown in Fig. 6 A. HSP 70 mRNA levels were increased as early as 1 h after the final reperfusion in the repetitive ischemia group, and this increase persisted to 4 h. By 24 h steady-state mRNA levels had returned to baseline. To quantitate changes in mRNA, all samples from the repetitive ischemia protocol, and four samples of RNA from normal rabbit hearts were compared using dot blot analysis. Densitometric quantitation for HSP 70 was then nor- At the completion ofthe protocol the hearts were sliced and stained with nitroblue tetrazolium. The two rabbits, in which there had been technical difficulty implanting the crystals with obvious localized occlusion of an arterial branch in one case and perforation of an arterial branch in the other, both had infarcts distal to the crystal sites. These two rabbits were excluded from analysis. In the other 10 rabbits there was no evidence of infarct in the area of ischemia. Fig. 6 A, indicated that collagen a 1 (IV) and G3PD mRNA do not undergo marked change during the experimental treatment in this study. The densitometry results, illustrated in Fig.  6 B, confirmed the marked increase in HSP 70 mRNA by 2 h (P < 0.001). Normalization of this data to either of the two control mRNAs established a threefold increase in HSP 70 mRNA compared with normal and sham hearts. This increase persisted at 4 h (P = 0.018), but had returned to normal by 24 h. In the hearts subjected to coronary occlusion for 2 h 35 min, matching the total protocol duration for the 2-h repetitive ischemia group, HSP 70 mRNA increased 6.5-8.5-fold when normalized to collagen 1a (IV) or G3PD, respectively (data not shown). HSP 70 mRNA expression in the nonischemic tissue samples from ventricles of the hearts subjected to repetitive ischemia were compared with samples from normal, untreated hearts and sham-operated controls. For the single 5-min occlusion no change occurred in the amount of HSP 70 mRNA in the nonischemic tissue compared with normal myocardium (data not shown). However, the nonischemic tissue from the repetitive occlusion protocol showed a twofold increase in expression compared with sham-operated controls (Fig. 7 A) .
The localization of HSP 70 mRNA in the normal rabbit heart was examined to determine if differences in the amount of HSP 70 mRNA occurred in the different regions ofthe heart. As shown in Fig. 7 B, the relative amount of HSP 70 mRNA was similar in the atria (left and right combined), right ventricle, septum, or left ventricular free wall.
Direct visualization ofdifferent isoforms of HSP 70 protein in homogenates ofcardiac tissue was performed by immunodetection after two-dimensional gel electrophoresis. As illustrated in Fig. 8 , as early as 2 h after repetitive ischemia/reperfusion there was an increase both in the amount and the number of immunoreactive isoforms. The most apparent change was an increase in the amount of the more basic isoforms, which was A clearly visualized both at 4 and 24 h after repetitive ischemia. These proteins, corresponding to the inducible members ofthe HSP 70 family, were barely detectable in control tissues, but were clearly visible in samples which underwent repetitive ischemia and reperfusion. Increases in the more acidic constitutive form also were evident.
Discussion
These studies provide new information on the mechanical changes in an in vivo rabbit heart model of stunning and show that changes in gene expression accompany the functional changes. The functional studies demonstrate that in the rabbit in vivo production of brief repetitive myocardial ischemia resulted in a mild stunning characterized by an increased enddiastolic and end-systolic length with preservation offractional shortening. End-systolic length increased significantly with each ischemic episode secondary to bulging of the ischemic wall. With each ischemia/reperfusion cycle, end-diastolic and end-systolic length gradually increased until they were significantly different from baseline 5 min into the final recovery period. Although the degree to which these values were increased lessened during the 3 h of recovery, they remained significantly elevated throughout. dL/dt was depressed after repetitive ischemia. These findings are consistent with an increase in preload (end-diastolic length) to maintain function (segmental shortening) in the face of decreased contractility (increased end-systolic length). In contrast, no increase in enddiastolic or end-systolic length occurred in the nonischemic myocardium during recovery. This combination ofan increase in end-diastolic length and end-systolic length with preservation of segmental shortening, but with a reduced velocity of shortening (dL/dt) and the absence of necrosis by nitroblue tetrazolium staining represents mild myocardial stunning. Although segment length and segmental shortening increased in the nonischemic myocardium during the ischemic periods, these changes resolved after reperfusion.
The those reported by Heyndrickx and co-workers (1, 31) . In these studies, which first reported the depression in myocardial function following transient ischemia, an increase in end-diastolic and end-systolic length was observed after a single 5-or 1 5-min occlusion of the canine left anterior descending coronary. These changes persisted for 3 h after a single 5-min occlusion and for > 6 h after a 1 5-min occlusion. Using subendocardial crystals Lange et al. (32) observed no lasting increase in segment length, but did observe prolonged depression of segment shortening after three 5-min or three 15-min coronary occlusions in the dog. The differences between these findings and our own could be attributed to placement ofthe crystals, which were localized midwall in the current study. Other studies suggesting that the subendocardium is more susceptible to ischemia than the subepicardium, would indicate that more profound abnormalities occur in the subendocardium after brief ischemia (33) (34) (35) . However, given the small size of the rabbit heart, it is technically difficult to place piezoelectric crystals in the subendocardium. Investigators have observed prolonged abnormalities ofwall thickening after brief ischemia in the dog, and this may be a more sensitive index of dysfunction than segmental shortening (1, 36) . Others have shown very prolonged depression of segmental shortening after ischemia of 2-h duration or longer in the dog (37, 38) . This dysfunction, which was accompanied by evidence of subendocardial necrosis, likely reflects a different phenomena, where the subepicardium is recruited to perform more work secondary to the irreversible damage in the subendocardial level, and is not comparable to the very mild ischemia which we used in our protocols. In previous studies from our laboratory much more severe mechanical stunning had been reported after the same repetitive ischemia protocol in the isolated blood-perfused rabbit heart (18) . One important difference between the two studies is that the ischemia in the isolated heart was global, eliminating the collateral flow, which amounts to 10-12% ofbaseline circulation in the in vivo coronary ligation model (39) .
These experiments demonstrate that alterations in gene expression, specifically an increase in HSP 70, were induced by a brief episode of ischemia, simulating the clinical condition of angina. A single 5-min coronary occlusion nearly doubled the steady-state level of HSP 70 mRNA, and with multiple occlusions, the experimental equivalent of unstable angina, HSP 70 mRNA levels were increased approximately threefold. The observed increase in HSP 70 mRNA was transient, occurring as early as 1 h after reperfusion and returning to control levels by 24 h. Furthermore, not only did the area of ischemia show a change in gene expression, but the nonischemic region of the ventricle also changed, though to a smaller degree. After a single coronary occlusion no change was detected in the nonischemic ventricle, but after four coronary occlusions this region of the ventricle had a twofold increase in HSP 70 mRNA. Thus brief anginal episodes are sufficient to change gene expression not only in the zone of ischemia, but also in the nonischemic tissue. In contrast, 2 h 35 min of ischemia without reperfusion resulted in a 6.5-8.5-fold increase in HSP 70 mRNA. This suggests that there is a graduated response to ischemia. Although brief ischemia resulted in a marked increase HSP 70 mRNA, more severe ischemia resulted in an even greater increase.
The mechanisms responsible for the altered HSP expression in the ischemic and nonischemic regions of the heart may reflect a relationship between the metabolic consequences of ischemia (i.e., tissue acidosis and hypoxia) and its mechanical effects. The nonischemic ventricle during ischemia would have had increased contractile work secondary to the increased load resulting from the severe hypokinesis and dyskinesis ofthe ischemic zone. Such an increased workload, or possibly an increased left ventricular end-diastolic pressure, may have resulted in the modest increase in HSP 70 expression in the nonischemic ventricle similar to acute pressure overload, which has been shown to increase HSP 70 expression (12, 13) .
Western blotting procedures demonstrated an increase in HSP 70 at the protein level along with a change in the number and relative amounts of isoforms after the repetitive ischemia/ reperfusion protocol. This increase was evident at 2 h, and was more marked at 24 h, by which time the mRNA levels had returned to normal. In control tissue, as shown in Fig. 8 , the most acidic isoform was the most prevalent form of the protein. After repetitive ischemia, the inducible forms of this protein family became far more prevalent and at least two more basic isoforms also were prominent. The induction by ischemia of a protein thought to function by blocking translation of other proteins, protecting protein structure, and associating with nucleoli during stress, has implications for myocardial function postischemia (9, 10, 15, 30, 40) . The known functions of HSP 70 suggest this protein may have a role in both stunning and preconditioning. Brief heat shock has been shown to protect against prolonged heat shock (40) as well as to enhance recovery from ischemia (41) . Both the induction of HSP 70 after very brief ischemia causing mild stunning and the preservation of function after its induction make it a strong candidate to contribute to the well-described conditioning effect of Murray et al. (4) . This same preconditioning has recently been reported in the rabbit (42) . Further studies need to be done to determine if HSP 70 induction before ischemia can have a protective or preconditioning effect in the heart.
The only previous reports of HSP 70 induction in the heart involved prolonged heat shock or ischemia of long enough duration to produce cell death (1 1, 43, 44) . Furthermore, although well-described in the canine model, myocardial stunning has not been previously described in the rabbit in vivo. In our studies we found mild stunning characterized by upward movement on the Starling curve which persisted for 3 h. A single 5-min period of ischemia in the rabbit was sufficient to induce expression ofHSP 70, and repetitive ischemia increased the expression. In the absence of further ischemia this was a transient response with resolution of the increase in HSP 70 mRNA by 24 h, although an increase in HSP 70 at the protein level was still present at 24 h. We have shown the alteration of protein expression occurs in an experimental model that produces mild postischemic dysfunction, and suggest it may play a role in the persistent abnormalities observed aftertransient ischemia. The suppression of the translation of other mRNAs by HSP 70 could prevent the resynthesis of important regulatory proteins. For example, the persistent abnormalities of purine metabolism after transient ischemia in the canine heart (2) might be explained by reduced synthesis of enzymes involved in purine metabolism. If HSP 70 is protective, as experiments so far indicate (10, 40, 41, 45) , regulation of HSP 70 has implications both for understanding the various ischemic conditions associated with coronary artery disease, as well as for the induced ischemia of cardioplegia.
